Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
301
Huya Inc
HUYA
$556M
| $92.8M | 0.07% |
5,172,500
+1,479,700
| +40% | +$31.3M |
|
302
Apple Hospitality REIT
APLE
$3.68B
| $92.6M | 0.07% |
5,698,888
+542,700
| +11% | +$8.78M |
|
|
TTM
303
DELISTED
Tata Motors Limited
TTM
| $92.2M | 0.07% |
7,130,208
+878,600
| +14% | +$9.68M |
|
304
Veeva Systems
VEEV
$38.4B
| $92.2M | 0.07% |
655,393
-646,010
| -50% | -$94.9M |
|
305
Brixmor Property Group
BRX
$9.09B
| $92M | 0.07% |
4,255,900
+61,100
| +1% | +$1.31M |
|
|
WNS
306
DELISTED
WNS Holdings
WNS
| $91.6M | 0.07% |
1,385,122
+55,222
| +4% | +$3.44M |
|
307
CoreCivic
CXW
$3.35B
| $91.5M | 0.07% |
5,264,371
+217,468
| +4% | +$3.44M |
|
308
Frontdoor
FTDR
$5.76B
| $91.4M | 0.07% |
1,928,418
+301,700
| +19% | +$14.1M |
|
309
Stryker
SYK
$134B
| $91M | 0.07% |
+433,500
| New | +$90M |
|
310
Strategic Education
STRA
$1.81B
| $90.6M | 0.07% |
570,392
-85,152
| -13% | -$11.8M |
|
311
FirstService
FSV
$6.3B
| $90.3M | 0.07% |
970,193
-16,400
| -2% | -$1.54M |
|
312
Omega Healthcare
OHI
$13.8B
| $90M | 0.07% |
2,124,764
-188,014
| -8% | -$7.96M |
|
313
Rio Tinto
RIO
$164B
| $89.9M | 0.07% |
1,515,232
+200,300
| +15% | +$10.9M |
|
314
Independence Realty Trust
IRT
$3.93B
| $89.6M | 0.07% |
6,363,821
+450,505
| +8% | +$6.56M |
|
315
Fox Class B
FOX
$23.2B
| $89.3M | 0.07% |
2,452,427
+219,900
| +10% | +$7.39M |
|
316
Honda
HMC
$41.1B
| $89.2M | 0.07% |
3,151,800
+245,000
| +8% | +$6.82M |
|
317
Agilent Technologies
A
$42.2B
| $89.2M | 0.07% |
1,045,096
-156,404
| -13% | -$12.3M |
|
318
Valvoline
VVV
$4.21B
| $89M | 0.07% |
4,155,224
+1,588,262
| +62% | +$35M |
|
|
EE
319
DELISTED
El Paso Electric Company
EE
| $88.7M | 0.07% |
1,306,119
-419,881
| -24% | -$28.3M |
|
320
Kearny Financial
KRNY
$600M
| $88.3M | 0.07% |
6,381,491
-74,025
| -1% | -$1.02M |
|
321
Moody's
MCO
$82.5B
| $88.2M | 0.07% |
371,422
+180,422
| +94% | +$40.1M |
|
322
WEC Energy
WEC
$34.8B
| $87.2M | 0.07% |
944,994
-1,469,927
| -61% | -$134M |
|
323
Affiliated Managers Group
AMG
$9.48B
| $87.1M | 0.07% |
1,027,592
+21,892
| +2% | +$1.8M |
|
324
Public Service Enterprise Group
PEG
$37.5B
| $86.7M | 0.07% |
1,468,049
+125,365
| +9% | +$7.6M |
|
325
Louisiana-Pacific
LPX
$5.28B
| $86.5M | 0.07% |
2,916,355
+38,337
| +1% | +$1.08M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.